Exsurgo co-founder and chief executive Richard Little recently featured on Lisa Tamati’s Pushing The Limits podcast, to discuss chronic pain and the effects it has on your mental and emotional health. Richard Little joined Lisa to talk about Exsurgo, and how their Axon product provides chronic pain relief. He also talks about how medical technology aids …
Exsurgo co-founder and chief executive Richard Little made a guest appearance on Doctor Aaron Tressler’s podcast, Restoring Innate Health. On this episode, Richard discusses the power off EEG neurofeedback for treating chronic pain and the connection between the brain and body.  Restoring Innate Health, previously known as the Making Pittsburgh Healthy podcast, is set out to empower …
It’s good to have plans, but it’s always better to have options. At Exsurgo, our plan was to launch the world’s biggest clinical trial of EEG Neurofeedback for the treatment of chronic pain, in conjunction with AUT and the Waitemata District Health Board. The nation’s latest staycation at alert level four has meant those plans …
Ryan Bridge, newly appointed host of The AM Show, spoke with Exsurgo Chief Science Officer, Christine Ozolins on the launch of the upcoming chronic pain trial in New Zealand. Christine discusses her role in the 116 chronic pain patient trial, along with some insights into how Axon rewires and treats the brain when suffering from …
The AM Show interviews Christine Ozolins on NZ chronic pain trial Read More »
Kathryn Ryan, the host of RadioNZ’s Nine to Noon, spoke with Richard Little about the launch of the world’s largest clinical trial using EEG neurofeedback, which can be listened to here. They discuss the growing burden of chronic pain on New Zealand’s healthcare systems and economy, and how Exsurgo’s Axon headset offers an alternative treatment …
RadioNZ’s Nine to Noon on retraining the brain’s response to chronic pain Read More »
The world’s biggest clinical trial using EEG neurofeedback as a therapy to manage chronic pain has been launched in New Zealand. Chronic pain (defined as pain that persists for longer than three months) affects up to one in five people around the world and is a massive burden on healthcare systems and economies. A 2018 …
Mike Hosking, the host of Newstalk ZB’s Morning Show, spoke with Richard Little about the launch of the AUT/WDHB trial that is now underway with 116 chronic pain patients from Auckland, which can be viewed here and listened to below. They discussed the potential for Axon to be rolled out to hospitals and medical clinics worldwide by mid …
Emma Russell, Health Reporter for the New Zealand Herald spoke with Richard Little about the launch of the AUT/WDHB trial that is now underway with 116 chronic pain patients from Auckland, which can be viewed here. They discussed the potential for Axon to be rolled out to hospitals and medical clinics worldwide by mid 2022, results …
